Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
 & Lead Plaintiff Deadline - March 27, 2017 - EconoTimes)
NEW YORK, March 23, 2017 -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (NASDAQ:RWLK) and certain of its officers, on behalf of a class who purchased ReWalk securities pursuant to the Company’s initial public offering (“IPO”) on or around September 12, 2014. Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/rwlk.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
ReWalk is a medical commercial bionic walking assistance system. The company designs, develops, and commercializes exoskeletons for wheelchair-bound individuals.
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements in its Registration Statement and Prospectus issued in regards with the Initial Public Offering did not disclose material information, including that ReWalk could not comply with “special controls” requirements or to offer the U.S. Food and Drug Administration with a post market surveillance study. Once this information was made public, ReWalk stock price dropped, causing investors harm.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/rwlk or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in ReWalk you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]
